Description:
RTR-5 is a synthetic research peptide available as a freeze-dried (lyophilized) powder. It is studied as Retatrutide peptide benefits for its unique profile as a tri-agonist with affinity for GLP-1, GIP, and glucagon receptors in laboratory research settings. Learn more about RTR-10, studied as Retatrutide peptide, benefits and learn how to buy below.
Product Details:
-
Compound: RTR-5 (studied as Retatrutide)
-
Form: Lyophilized powder
-
Amount: 5mg per vial
-
Appearance: White/off-white powder
-
Purity: >99% (HPLC Verified)
-
Molecular Formula: C190H282N48O60
-
Storage: Store at -20°C in a dry, dark place
Intended Use:
This compound is intended for laboratory research use only. It is not intended for human consumption, medical, or diagnostic purposes.
Related Research Studies:
- Retatrutide as a novel triple hormone receptor agonist for type 2 diabetes and obesity (PubMed) – This study evaluates Retatrutide’s action on GLP‑1, GIP, and glucagon receptors and its potential effects on weight management in research settings.
- Clinical Trial: Retatrutide for Weight Management (ClinicalTrials.gov) – Ongoing research evaluating Retatrutide peptide’s safety and efficacy in controlled clinical settings for obesity and related metabolic conditions.
-
Related Blog: Inside the Research on the GLP‑1/GIP Dual Agonist Retatrutide Peptide
Findings:
Research on Retatrutide has observed potential benefits related to GLP‑1, GIP, and glucagon receptor activity in metabolic studies.
Related Products:
